Загрузка...
Clinical and Immunological Outcome in Cutaneous Leishmaniasis Patients Treated with Pentoxifylline
Pentoxifylline is a tumor necrosis factor-α (TNF-α) inhibitor that also attenuates the immune response and decreases tissue inflammation. The association of pentoxifylline with antimony improves the cure rate of mucosal and cutaneous leishmaniasis. In this randomized and double blind pilot trial, cu...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The American Society of Tropical Medicine and Hygiene
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3973503/ https://ncbi.nlm.nih.gov/pubmed/24567316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.12-0729 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|